Chisato Ohe Selected Research

Chisato Ohe Research Topics

20	Neoplasms (Cancer) 01/2022 - 02/2009
10	Renal Cell Carcinoma (Grawitz Tumor) 02/2022 - 06/2012
7	Carcinoma (Carcinomatosis) 11/2022 - 11/2016
5	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2009
3	Adenocarcinoma 09/2021 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2014
3	Leiomyomatosis 01/2018 - 11/2016
3	renal Oncocytoma 08/2013 - 06/2011
2	Medullary Carcinoma 05/2018 - 01/2018
1	Hyperplasia 12/2021
1	Adenoma (Adenomas) 12/2021
1	Hyperaldosteronism (Conn Syndrome) 12/2021
1	Familial Hyperaldosteronism 12/2021
1	3 Autosomal Dominant Hypercholesterolemia 12/2021
1	Neuroendocrine Carcinoma 09/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2021
1	Hereditary leiomyomatosis and renal cell cancer 12/2020
1	Extranodal Extension 01/2019
1	Mucoepidermoid Carcinoma 04/2018
1	Hemoglobinopathies 01/2018
1	Ascites 01/2017
1	Diarrhea 01/2017
1	Sickle Cell Trait 01/2017
1	Thymoma (Thymic Carcinoma) 02/2016
1	Pulmonary Arterial Hypertension 12/2014
1	Osteopetrosis 12/2014
1	Melanoma (Melanoma, Malignant) 04/2013
1	Glaucoma 04/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2012
1	Lymphatic Metastasis 04/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012
1	Autoimmune Pancreatitis 01/2012
1	Chronic Pancreatitis 01/2012
1	Pancreatitis 01/2012
1	Hypertension (High Blood Pressure) 08/2011
1	Hypokalemia 08/2011
1	Hemorrhage 08/2011
1	Rupture 12/2010
1	Cysts 12/2010
1	Necrosis 02/2009

5	Fumarate Hydratase (Fumarase)IBA 12/2020 - 11/2016
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 03/2021
3	Hematoxylin (Haematoxylon)IBA 01/2022 - 03/2021
3	Chromogranin AIBA 09/2021 - 01/2010
3	SynaptophysinIBA 09/2021 - 01/2010
3	Keratins (Keratin)IBA 03/2021 - 02/2010
3	Keratin-7 (Cytokeratin 7)IBA 08/2015 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 08/2013
2	AcidsIBA 06/2021 - 01/2015
2	Biological ProductsIBA 01/2017 - 01/2014
2	Capsules (Microcapsules)IBA 01/2014 - 08/2011
2	AntigensIBA 08/2013 - 06/2012
2	VimentinIBA 08/2011 - 02/2010
1	Immune Checkpoint InhibitorsIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	entrectinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AldosteroneIBA 12/2021
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2021
1	CateninsIBA 12/2021
1	Uroplakin IIIBA 03/2021
1	Phenobarbital (Luminal)FDA Link 03/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	Acetates (Acetic Acid Esters)FDA Link 01/2019
1	MucinsIBA 04/2018
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 07/2017
1	CD5 AntigensIBA 02/2016
1	Cadherins (E-Cadherin)IBA 02/2016
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2015
1	ChromatinIBA 03/2014
1	CollagenIBA 01/2014
1	ElementsIBA 04/2013
1	Epithelial Cell Adhesion MoleculeIBA 06/2012
1	Immunoglobulin G (IgG)IBA 01/2012
1	GelsIBA 01/2012
1	ReninIBA 08/2011
1	S100A1 proteinIBA 06/2011
1	OxalatesIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2010
1	GlycogenIBA 02/2009

2	Therapeutics 11/2022 - 04/2012
2	Prostatectomy (Retropubic Prostatectomy) 05/2020 - 04/2014
2	Pancreatectomy 01/2017 - 04/2012
1	Immunotherapy 11/2022
1	Adrenalectomy 12/2021
1	Lasers (Laser) 06/2021
1	Oral Administration 06/2021
1	Laser Therapy (Surgery, Laser) 06/2021
1	Nephrectomy 03/2020
1	Thymectomy 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Adjuvant Chemotherapy 01/2017
1	Neoadjuvant Therapy 01/2017
1	Hematopoietic Stem Cell Transplantation 12/2014
1	Renal Dialysis (Hemodialysis) 11/2012
1	Splenectomy 12/2010
1	Radiotherapy 02/2009